Growth Metrics

Globus Medical (GMED) Gross Profit (2016 - 2025)

Globus Medical's Gross Profit history spans 15 years, with the latest figure at $565.3 million for Q4 2025.

  • For Q4 2025, Gross Profit rose 43.53% year-over-year to $565.3 million; the TTM value through Dec 2025 reached $2.0 billion, up 33.51%, while the annual FY2025 figure was $2.0 billion, 33.51% up from the prior year.
  • Gross Profit reached $565.3 million in Q4 2025 per GMED's latest filing, up from $516.5 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $565.3 million in Q4 2025 to a low of $171.2 million in Q3 2021.
  • Average Gross Profit over 5 years is $298.2 million, with a median of $231.7 million recorded in 2023.
  • Peak YoY movement for Gross Profit: surged 90.45% in 2021, then fell 0.54% in 2022.
  • A 5-year view of Gross Profit shows it stood at $188.2 million in 2021, then grew by 8.33% to $203.9 million in 2022, then surged by 72.16% to $351.0 million in 2023, then increased by 12.19% to $393.9 million in 2024, then soared by 43.53% to $565.3 million in 2025.
  • Per Business Quant, the three most recent readings for GMED's Gross Profit are $565.3 million (Q4 2025), $516.5 million (Q3 2025), and $496.6 million (Q2 2025).